Was Dr. Bunn Insensitive Or Just Efficient? FDA Imbroglio Points To Larger Problems
In Brief: ASTRO Officers Named; AACR Fellowships Available; NRC Won’t Revoke NIH License
FDA Likely To Change Procedures For Patient Interaction, Official Says
RPR Grant To NABCO Does Not Support Advocacy, Firm Says
ODAC Chairman: Time Was Tight For Meeting
Trending Stories
- As daraxonrasib hits the clinic, Frank McCormick says RAS is bigger than pancreatic cancer
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Cancer leaders play “musical chairs” as executive jobs fill at top cancer centers
Lee replaces Pisters at MD Anderson, Tuveson moves to Duke, and Mitchell is named director at University of Florida - KRAS pioneer and Stephenson Prize winner Frank McCormick aims to prevent all KRAS cancers with a pill
- From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma









